menu
    • menu
    [{"orgOrder":0,"company":"POM Wonderful","sponsor":"Target Health Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2010","type":"Inapplicable","leadProduct":"Ellagic acid","moa":"Immune","graph1":"Psychiatry\/Psychology","graph2":"Phase II","graph3":"POM Wonderful","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Capsule","sponsorNew":"POM Wonderful \/ Target Health Inc.","highestDevelopmentStatusID":"8","companyTruncated":"POM Wonderful \/ Target Health Inc."},{"orgOrder":0,"company":"POM Wonderful","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2010","type":"Inapplicable","leadProduct":"Ellagic acid","moa":"Immune","graph1":"Musculoskeletal","graph2":"Phase I","graph3":"POM Wonderful","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"POM Wonderful \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"POM Wonderful \/ Undisclosed"},{"orgOrder":0,"company":"Vancouver Coastal Health","sponsor":"Lotte & John Hecht Memorial Foundation","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"CANADA","productType":"Plant Extract\/Herbal","year":"2010","type":"Inapplicable","leadProduct":"Ellagic acid","moa":"Immune","graph1":"Oncology","graph2":"Undisclosed","graph3":"Vancouver Coastal Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Vancouver Coastal Health \/ Lotte & John Hecht Memorial Foundation","highestDevelopmentStatusID":"1","companyTruncated":"Vancouver Coastal Health \/ Lotte & John Hecht Memorial Foundation"},{"orgOrder":0,"company":"Integrative Skin Science and Research","sponsor":"Verdure Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Ellagic acid","moa":"Immune","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Integrative Skin Science and Research","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Integrative Skin Science and Research \/ Verdure Sciences","highestDevelopmentStatusID":"1","companyTruncated":"Integrative Skin Science and Research \/ Verdure Sciences"},{"orgOrder":0,"company":"Alchem International Private Ltd","sponsor":"AIIMS","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Curcuminoid","moa":"||Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Alchem International Private Ltd","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Troche\/Lozenge","sponsorNew":"Alchem International Private Ltd \/ AIIMS","highestDevelopmentStatusID":"1","companyTruncated":"Alchem International Private Ltd \/ AIIMS"},{"orgOrder":0,"company":"University of California, Los Angeles","sponsor":"POM Wonderful","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2014","type":"Inapplicable","leadProduct":"Ellagic acid","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase II","graph3":"University of California, Los Angeles","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of California, Los Angeles \/ POM Wonderful","highestDevelopmentStatusID":"8","companyTruncated":"University of California, Los Angeles \/ POM Wonderful"},{"orgOrder":0,"company":"POM Wonderful","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2012","type":"Inapplicable","leadProduct":"Ellagic acid","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Phase I","graph3":"POM Wonderful","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"POM Wonderful \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"POM Wonderful \/ Undisclosed"},{"orgOrder":0,"company":"Brigham and Women's Hospital","sponsor":"University of California, Los Angeles | POM Wonderful","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2020","type":"Inapplicable","leadProduct":"Ellagic acid","moa":"Undisclosed","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Undisclosed","graph3":"Brigham and Women's Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Brigham and Women's Hospital \/ University of California, Los Angeles | POM Wonderful","highestDevelopmentStatusID":"1","companyTruncated":"Brigham and Women's Hospital \/ University of California, Los Angeles | POM Wonderful"},{"orgOrder":0,"company":"University of Texas at Austin","sponsor":"POM Wonderful","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2017","type":"Inapplicable","leadProduct":"Ellagic acid","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"University of Texas at Austin","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Texas at Austin \/ POM Wonderful","highestDevelopmentStatusID":"1","companyTruncated":"University of Texas at Austin \/ POM Wonderful"}]

    Find Clinical Drug Pipeline Developments & Deals for Diphenic acid, 4,4',5,5',6,6'-hexahydroxy-, di-delta-lactone

    Menu

    Diphenic acid, 4,4',5,5',6,6'-hexahydroxy-, di-delta-lactone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Alchem International Private Ltd

                            India
                            CPhI WW Frankfurt
                            Booth #11.0C48
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothAlchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

                            Lead Product(s) : Curcuminoid,Ellagic acid,Gingerol

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Sponsor : AIIMS

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            AIIMS Patna Confirms efficacy of AlchemLife’s Phytorelief a Natural Anti-Viral for Mild to Moderate Covid-19...

                            Details : After ten days of treatment with Phytorelief along with standard management, 83% of Covid-19 patients, with mild or moderate symptoms, turned negative in a trial conduct in AIIMS Patna.

                            Product Name : Phytorelief-CC

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            June 10, 2021

                            Lead Product(s) : Curcuminoid,Ellagic acid,Gingerol

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : AIIMS

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            Alchem

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Integrative Skin Science and Research

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed

                            Integrative Skin Science and Research

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Verdure Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties

                            Details : Pomegranate extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            October 22, 2020

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Verdure Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Brigham and Women's Hospital

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed

                            Brigham and Women's Hospital

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                            Study Phase : Undisclosed

                            Sponsor : University of California, Los Angeles | POM Wonderful

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Impact of Antioxidant Juice Intake on Brain Injury and Placental Pathology in Infants With Intrauterine Growth...

                            Details : Pomegranate juice is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Intrauterine Growth Restriction.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            May 20, 2020

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                            Highest Development Status : Undisclosed

                            Sponsor : University of California, Los Angeles | POM Wonderful

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            University of Texas at Austin

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed

                            University of Texas at Austin

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Undisclosed

                            Sponsor : POM Wonderful

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Reversing Muscle Loss With Exercise Training and Daily Consumption of Pomegranate Juice

                            Details : Pomegranate juice is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Sarcopenia.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            August 23, 2017

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Undisclosed

                            Sponsor : POM Wonderful

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            University of California, Los Angeles

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed

                            University of California, Los Angeles

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase II

                            Sponsor : POM Wonderful

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study of Pomegranate Juice on Memory in Older Adults

                            Details : Pomegranate juice is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            March 20, 2014

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase II

                            Sponsor : POM Wonderful

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            POM Wonderful

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed

                            POM Wonderful

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Endocrinology

                            Study Phase : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers

                            Details : Pomegranate juice is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Infertility, Male.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            May 10, 2012

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            POM Wonderful

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed

                            POM Wonderful

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Psychiatry/Psychology

                            Study Phase : Phase II

                            Sponsor : Target Health Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            POMx In the Treatment of Erectile Dysfunction

                            Details : POMx Extract (pomegranate extract) is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Erectile Dysfunction.

                            Product Name : POMx Extract

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            October 13, 2010

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Psychiatry/Psychology

                            Highest Development Status : Phase II

                            Sponsor : Target Health Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            POM Wonderful

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed

                            POM Wonderful

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Pomegranate Extract Biomarker Study in Osteopenic Women

                            Details : Pomegranate extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Bone Diseases, Metabolic.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            October 13, 2010

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            Vancouver Coastal Health

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed

                            Vancouver Coastal Health

                            Country arrow
                            IPEX Indonesia
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Oncology

                            Study Phase : Undisclosed

                            Sponsor : Lotte & John Hecht Memorial Foundation

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study of POMELLAâ„¢ Extract to Treat Prostate Cancer

                            Details : Pomegranate extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Prostatic Neoplasms.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            April 09, 2010

                            Lead Product(s) : Ellagic acid

                            Therapeutic Area : Oncology

                            Highest Development Status : Undisclosed

                            Sponsor : Lotte & John Hecht Memorial Foundation

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth